JP2004525876A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004525876A5 JP2004525876A5 JP2002552914A JP2002552914A JP2004525876A5 JP 2004525876 A5 JP2004525876 A5 JP 2004525876A5 JP 2002552914 A JP2002552914 A JP 2002552914A JP 2002552914 A JP2002552914 A JP 2002552914A JP 2004525876 A5 JP2004525876 A5 JP 2004525876A5
- Authority
- JP
- Japan
- Prior art keywords
- oxo
- oxazolan
- salt
- phenyl
- fluoro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000003839 salts Chemical class 0.000 claims description 303
- -1 pyrrolidinylthiocarbonyl Chemical group 0.000 claims description 114
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 49
- 150000001875 compounds Chemical class 0.000 claims description 18
- HXIRTSKHPFRRKO-UHFFFAOYSA-N o-methyl carbamothioate Chemical compound COC(N)=S HXIRTSKHPFRRKO-UHFFFAOYSA-N 0.000 claims description 13
- GTCAXTIRRLKXRU-UHFFFAOYSA-N carbamic acid methyl ester Natural products COC(N)=O GTCAXTIRRLKXRU-UHFFFAOYSA-N 0.000 claims description 10
- XYVMOLOUBJBNBF-UHFFFAOYSA-N 3h-1,3-oxazol-2-one Chemical compound OC1=NC=CO1 XYVMOLOUBJBNBF-UHFFFAOYSA-N 0.000 claims description 8
- ZWWAJMUJXCLKDI-UHFFFAOYSA-N ethylsulfanyl carbamate Chemical compound C(N)(=O)OSCC ZWWAJMUJXCLKDI-UHFFFAOYSA-N 0.000 claims description 7
- 125000006533 methyl amino methyl group Chemical group [H]N(C([H])([H])[H])C([H])([H])* 0.000 claims description 6
- 125000000464 thioxo group Chemical group S=* 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 4
- BLBQHONHPVUNNA-SECBINFHSA-N (5r)-3-[2-fluoro-4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-5-(hydroxymethyl)-1,3-oxazolidin-2-one Chemical compound O=C1O[C@@H](CO)CN1C1=CC=C(N2C(OCC2)=O)C=C1F BLBQHONHPVUNNA-SECBINFHSA-N 0.000 claims description 2
- UVKKXZAOOHKQGK-SECBINFHSA-N (5r)-3-[3-fluoro-4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-5-(hydroxymethyl)-1,3-oxazolidin-2-one Chemical compound O=C1O[C@@H](CO)CN1C(C=C1F)=CC=C1N1C(=O)OCC1 UVKKXZAOOHKQGK-SECBINFHSA-N 0.000 claims description 2
- BAWYOZIGOLWAPE-OAHLLOKOSA-N (5r)-3-[3-fluoro-4-(2-oxo-3-phenylimidazolidin-1-yl)phenyl]-5-(hydroxymethyl)-1,3-oxazolidin-2-one Chemical compound O=C1O[C@@H](CO)CN1C(C=C1F)=CC=C1N1C(=O)N(C=2C=CC=CC=2)CC1 BAWYOZIGOLWAPE-OAHLLOKOSA-N 0.000 claims description 2
- PHBJXIQJUQZHSI-SECBINFHSA-N (5r)-3-[3-fluoro-4-(2-sulfanylidene-1,3-oxazolidin-3-yl)phenyl]-5-(hydroxymethyl)-1,3-oxazolidin-2-one Chemical compound O=C1O[C@@H](CO)CN1C(C=C1F)=CC=C1N1C(=S)OCC1 PHBJXIQJUQZHSI-SECBINFHSA-N 0.000 claims description 2
- KGCOHZKSIRCQDH-SNVBAGLBSA-N (5r)-3-[3-fluoro-4-(3-methyl-2-oxoimidazolidin-1-yl)phenyl]-5-(hydroxymethyl)-1,3-oxazolidin-2-one Chemical compound O=C1N(C)CCN1C1=CC=C(N2C(O[C@@H](CO)C2)=O)C=C1F KGCOHZKSIRCQDH-SNVBAGLBSA-N 0.000 claims description 2
- DZHVONJUCHHDJE-SNVBAGLBSA-N (5r)-3-[3-fluoro-4-(3-methyl-2-sulfanylideneimidazolidin-1-yl)phenyl]-5-(hydroxymethyl)-1,3-oxazolidin-2-one Chemical compound S=C1N(C)CCN1C1=CC=C(N2C(O[C@@H](CO)C2)=O)C=C1F DZHVONJUCHHDJE-SNVBAGLBSA-N 0.000 claims description 2
- KIIOFADAAYVPRJ-SNVBAGLBSA-N (5r)-3-[3-fluoro-4-(3-methyl-4-oxoimidazolidin-1-yl)phenyl]-5-(hydroxymethyl)-1,3-oxazolidin-2-one Chemical compound C1C(=O)N(C)CN1C1=CC=C(N2C(O[C@@H](CO)C2)=O)C=C1F KIIOFADAAYVPRJ-SNVBAGLBSA-N 0.000 claims description 2
- ZVXJDSDSXAJDMX-CYBMUJFWSA-N (5r)-3-[3-fluoro-4-[3-(2-fluorophenyl)-2-oxoimidazolidin-1-yl]phenyl]-5-(hydroxymethyl)-1,3-oxazolidin-2-one Chemical compound O=C1O[C@@H](CO)CN1C(C=C1F)=CC=C1N1C(=O)N(C=2C(=CC=CC=2)F)CC1 ZVXJDSDSXAJDMX-CYBMUJFWSA-N 0.000 claims description 2
- LRLPGFQPBBUZCS-QGZVFWFLSA-N (5r)-3-[3-fluoro-4-[3-[(4-methoxyphenyl)methyl]-4-oxoimidazolidin-1-yl]phenyl]-5-(hydroxymethyl)-1,3-oxazolidin-2-one Chemical compound C1=CC(OC)=CC=C1CN1C(=O)CN(C=2C(=CC(=CC=2)N2C(O[C@@H](CO)C2)=O)F)C1 LRLPGFQPBBUZCS-QGZVFWFLSA-N 0.000 claims description 2
- DWATUUKBXZBUNF-GOSISDBHSA-N (5r)-3-[4-(3-benzyl-2-oxoimidazolidin-1-yl)phenyl]-5-(hydroxymethyl)-1,3-oxazolidin-2-one Chemical compound O=C1O[C@@H](CO)CN1C1=CC=C(N2C(N(CC=3C=CC=CC=3)CC2)=O)C=C1 DWATUUKBXZBUNF-GOSISDBHSA-N 0.000 claims description 2
- NHHFXULAHBKCJV-SNVBAGLBSA-N (5r)-5-(aminomethyl)-3-[3-fluoro-4-(3-methyl-4-oxoimidazolidin-1-yl)phenyl]-1,3-oxazolidin-2-one Chemical compound C1C(=O)N(C)CN1C1=CC=C(N2C(O[C@H](CN)C2)=O)C=C1F NHHFXULAHBKCJV-SNVBAGLBSA-N 0.000 claims description 2
- CKONPXQNHZXJQM-LLVKDONJSA-N (5r)-5-(aminomethyl)-3-[4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-1,3-oxazolidin-2-one Chemical compound O=C1O[C@H](CN)CN1C1=CC=C(N2C(OCC2)=O)C=C1 CKONPXQNHZXJQM-LLVKDONJSA-N 0.000 claims description 2
- XFFMZCPPUQOLRW-MRXNPFEDSA-N (5r)-5-(aminomethyl)-3-[4-(3-benzyl-4-oxoimidazolidin-1-yl)-3-fluorophenyl]-1,3-oxazolidin-2-one Chemical compound O=C1O[C@H](CN)CN1C(C=C1F)=CC=C1N1CC(=O)N(CC=2C=CC=CC=2)C1 XFFMZCPPUQOLRW-MRXNPFEDSA-N 0.000 claims description 2
- BAUYXWOSBYZLIU-VIFPVBQESA-N (5r)-5-(azidomethyl)-3-[2-fluoro-4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-1,3-oxazolidin-2-one Chemical compound FC1=CC(N2C(OCC2)=O)=CC=C1N1C[C@H](CN=[N+]=[N-])OC1=O BAUYXWOSBYZLIU-VIFPVBQESA-N 0.000 claims description 2
- QALSJZZTUUVZIF-HNNXBMFYSA-N (5r)-5-(azidomethyl)-3-[3-fluoro-4-(2-oxo-3-phenylimidazolidin-1-yl)phenyl]-1,3-oxazolidin-2-one Chemical compound FC1=CC(N2C(O[C@@H](CN=[N+]=[N-])C2)=O)=CC=C1N(C1=O)CCN1C1=CC=CC=C1 QALSJZZTUUVZIF-HNNXBMFYSA-N 0.000 claims description 2
- JDLVKYPUHDGXCQ-HNNXBMFYSA-N (5r)-5-(azidomethyl)-3-[3-fluoro-4-[3-(4-fluorophenyl)-2-oxoimidazolidin-1-yl]phenyl]-1,3-oxazolidin-2-one Chemical compound C1=CC(F)=CC=C1N1C(=O)N(C=2C(=CC(=CC=2)N2C(O[C@@H](CN=[N+]=[N-])C2)=O)F)CC1 JDLVKYPUHDGXCQ-HNNXBMFYSA-N 0.000 claims description 2
- IIGHHEQDSXWERE-VIFPVBQESA-N (5r)-5-(azidomethyl)-3-[4-(2-oxo-1,3-oxazolidin-3-yl)-3-(trifluoromethyl)phenyl]-1,3-oxazolidin-2-one Chemical compound FC(F)(F)C1=CC(N2C(O[C@@H](CN=[N+]=[N-])C2)=O)=CC=C1N1CCOC1=O IIGHHEQDSXWERE-VIFPVBQESA-N 0.000 claims description 2
- XQSQMKJQLZRECH-NSHDSACASA-N (5r)-5-(azidomethyl)-3-[4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-1,3-oxazolidin-2-one Chemical compound O=C1O[C@@H](CN=[N+]=[N-])CN1C1=CC=C(N2C(OCC2)=O)C=C1 XQSQMKJQLZRECH-NSHDSACASA-N 0.000 claims description 2
- OINZERVIURVBLV-LLVKDONJSA-N (5r)-5-(hydroxymethyl)-3-[4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-1,3-oxazolidin-2-one Chemical compound O=C1O[C@@H](CO)CN1C1=CC=C(N2C(OCC2)=O)C=C1 OINZERVIURVBLV-LLVKDONJSA-N 0.000 claims description 2
- HLEXURKWLRGWFI-GFCCVEGCSA-N (5r)-5-(hydroxymethyl)-3-[4-(3-methyl-2-oxoimidazolidin-1-yl)phenyl]-1,3-oxazolidin-2-one Chemical compound O=C1N(C)CCN1C1=CC=C(N2C(O[C@@H](CO)C2)=O)C=C1 HLEXURKWLRGWFI-GFCCVEGCSA-N 0.000 claims description 2
- VBFKULVORCOUMG-ZVAWYAOSSA-N (5s)-5-(benzylamino)-n-methyl-2-oxo-3-[4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-1,3-oxazolidine-4-carbothioamide Chemical compound N([C@@H]1C(N(C(=O)O1)C=1C=CC(=CC=1)N1C(OCC1)=O)C(=S)NC)CC1=CC=CC=C1 VBFKULVORCOUMG-ZVAWYAOSSA-N 0.000 claims description 2
- XIERWZVYMRJAJI-WMCAAGNKSA-N (5s)-5-(diethylamino)-n-methyl-2-oxo-3-[4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-1,3-oxazolidine-4-carbothioamide Chemical compound CNC(=S)C1[C@@H](N(CC)CC)OC(=O)N1C1=CC=C(N2C(OCC2)=O)C=C1 XIERWZVYMRJAJI-WMCAAGNKSA-N 0.000 claims description 2
- BLLBBEDABBPFCU-DTIOYNMSSA-N (5s)-5-amino-3-[3,5-difluoro-4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-n-methyl-2-oxo-1,3-oxazolidine-4-carbothioamide Chemical compound CNC(=S)C1[C@@H](N)OC(=O)N1C(C=C1F)=CC(F)=C1N1C(=O)OCC1 BLLBBEDABBPFCU-DTIOYNMSSA-N 0.000 claims description 2
- VDNPPCHXWLZCMT-DTIOYNMSSA-N (5s)-5-amino-3-[3-fluoro-4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-n-methyl-2-oxo-1,3-oxazolidine-4-carbothioamide Chemical compound CNC(=S)C1[C@@H](N)OC(=O)N1C(C=C1F)=CC=C1N1C(=O)OCC1 VDNPPCHXWLZCMT-DTIOYNMSSA-N 0.000 claims description 2
- FOSWJTIQKBXZJP-DAFXYXGESA-N (5s)-5-cyclohexyloxy-n-methyl-2-oxo-3-[4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-1,3-oxazolidine-4-carbothioamide Chemical compound O([C@@H]1C(N(C(=O)O1)C=1C=CC(=CC=1)N1C(OCC1)=O)C(=S)NC)C1CCCCC1 FOSWJTIQKBXZJP-DAFXYXGESA-N 0.000 claims description 2
- RUCBXHSEPGMBLW-KIYNQFGBSA-N (5s)-n-methyl-5-(methylamino)-2-oxo-3-[4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-1,3-oxazolidine-4-carbothioamide Chemical compound CNC(=S)C1[C@@H](NC)OC(=O)N1C1=CC=C(N2C(OCC2)=O)C=C1 RUCBXHSEPGMBLW-KIYNQFGBSA-N 0.000 claims description 2
- DDJBPAZIWNPETA-JTQLQIEISA-N 3,3,3-trifluoro-n-[[(5s)-3-[3-fluoro-4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]propanethioamide Chemical compound FC1=CC(N2C(O[C@@H](CNC(=S)CC(F)(F)F)C2)=O)=CC=C1N1CCOC1=O DDJBPAZIWNPETA-JTQLQIEISA-N 0.000 claims description 2
- PUDJFHDYXJWUNK-LLVKDONJSA-N 3-[2-fluoro-4-[(5r)-5-(hydroxymethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]-1,3-benzoxazol-2-one Chemical compound O=C1O[C@@H](CO)CN1C1=CC=C(N2C(OC3=CC=CC=C32)=O)C(F)=C1 PUDJFHDYXJWUNK-LLVKDONJSA-N 0.000 claims description 2
- BBJGFPLUXPZDOT-GFCCVEGCSA-N 3-[2-fluoro-4-[(5r)-5-(hydroxymethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]-5-methyl-1,3-benzoxazol-2-one Chemical compound C12=CC(C)=CC=C2OC(=O)N1C(C(=C1)F)=CC=C1N1C[C@H](CO)OC1=O BBJGFPLUXPZDOT-GFCCVEGCSA-N 0.000 claims description 2
- KOKHCSRXWRFLSR-GFCCVEGCSA-N 3-[2-fluoro-4-[(5r)-5-(hydroxymethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]-6-methyl-1,3-benzoxazol-2-one Chemical compound O=C1OC2=CC(C)=CC=C2N1C(C(=C1)F)=CC=C1N1C[C@H](CO)OC1=O KOKHCSRXWRFLSR-GFCCVEGCSA-N 0.000 claims description 2
- BJLXDGPGCZOLJV-CYBMUJFWSA-N 3-[4-[(5r)-5-(hydroxymethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]-1,3-benzoxazol-2-one Chemical compound O=C1O[C@@H](CO)CN1C1=CC=C(N2C(OC3=CC=CC=C32)=O)C=C1 BJLXDGPGCZOLJV-CYBMUJFWSA-N 0.000 claims description 2
- VJCYBKWVFJXADA-UHFFFAOYSA-N 4-(methylaminomethyl)-3-[4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-5-sulfanylidene-1,3-oxazolidin-2-one Chemical compound S=C1C(N(C(O1)=O)C1=CC=C(C=C1)N1C(OCC1)=O)CNC VJCYBKWVFJXADA-UHFFFAOYSA-N 0.000 claims description 2
- WTEHAQPVNFLKGP-UHFFFAOYSA-N CC(=O)ONC(=O)S Chemical compound CC(=O)ONC(=O)S WTEHAQPVNFLKGP-UHFFFAOYSA-N 0.000 claims description 2
- PNJVWWYGDFJNAW-KZUDCZAMSA-N CCC(C[C@H]1CN(C(=O)O1)C2=CC=C(C=C2)N3CCOC3=O)OC(=S)N Chemical compound CCC(C[C@H]1CN(C(=O)O1)C2=CC=C(C=C2)N3CCOC3=O)OC(=S)N PNJVWWYGDFJNAW-KZUDCZAMSA-N 0.000 claims description 2
- HJYWCRBBLPBUKJ-NSHDSACASA-N O-[[(5S)-2-oxo-3-[4-(2-oxo-1,3-oxazolidin-3-yl)-3-(trifluoromethyl)phenyl]-1,3-oxazolidin-5-yl]methyl] N-ethylcarbamothioate Chemical compound C(C)NC(OC[C@@H]1CN(C(O1)=O)C1=CC(=C(C=C1)N1C(OCC1)=O)C(F)(F)F)=S HJYWCRBBLPBUKJ-NSHDSACASA-N 0.000 claims description 2
- YVEDNBNDNMJOSJ-UHFFFAOYSA-N ethylcarbamothioic S-acid hydrochloride Chemical compound Cl.C(C)NC(O)=S YVEDNBNDNMJOSJ-UHFFFAOYSA-N 0.000 claims description 2
- WPHZNBYILLHZJI-LSLKUGRBSA-N n-[(2-hydroxyethylamino)-[(5s)-2-oxo-3-[4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-1,3-oxazolidin-5-yl]methyl]methanethioamide Chemical compound O=C1O[C@H](C(NC=S)NCCO)CN1C1=CC=C(N2C(OCC2)=O)C=C1 WPHZNBYILLHZJI-LSLKUGRBSA-N 0.000 claims description 2
- VENCFWWWNQTOOE-LSLKUGRBSA-N n-[2-hydroxyethoxy-[(5s)-2-oxo-3-[4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-1,3-oxazolidin-5-yl]methyl]methanethioamide Chemical compound O=C1O[C@H](C(NC=S)OCCO)CN1C1=CC=C(N2C(OCC2)=O)C=C1 VENCFWWWNQTOOE-LSLKUGRBSA-N 0.000 claims description 2
- VPONQLPTJTZNDG-MLCCFXAWSA-N n-[2-methoxyethoxy-[(5s)-2-oxo-3-[4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-1,3-oxazolidin-5-yl]methyl]methanethioamide Chemical compound O=C1O[C@H](C(NC=S)OCCOC)CN1C1=CC=C(N2C(OCC2)=O)C=C1 VPONQLPTJTZNDG-MLCCFXAWSA-N 0.000 claims description 2
- DKBQLCSTCPFPDK-PYNWJHIZSA-N n-[[(2s)-2-(hydroxymethyl)pyrrolidin-1-yl]-[(5s)-2-oxo-3-[4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-1,3-oxazolidin-5-yl]methyl]methanethioamide Chemical compound OC[C@@H]1CCCN1C(NC=S)[C@H]1OC(=O)N(C=2C=CC(=CC=2)N2C(OCC2)=O)C1 DKBQLCSTCPFPDK-PYNWJHIZSA-N 0.000 claims description 2
- RWNYNKUBRVZGDE-HNNXBMFYSA-N n-[[(5s)-2-oxo-3-[4-(2-oxo-1,3-benzoxazol-3-yl)phenyl]-1,3-oxazolidin-5-yl]methyl]acetamide Chemical compound O=C1O[C@@H](CNC(=O)C)CN1C1=CC=C(N2C(OC3=CC=CC=C32)=O)C=C1 RWNYNKUBRVZGDE-HNNXBMFYSA-N 0.000 claims description 2
- DCOQTEQWWQSBAB-NSHDSACASA-N n-[[(5s)-2-oxo-3-[4-(2-oxo-1,3-oxazolidin-3-yl)-3-(trifluoromethyl)phenyl]-1,3-oxazolidin-5-yl]methyl]acetamide Chemical compound O=C1O[C@@H](CNC(=O)C)CN1C(C=C1C(F)(F)F)=CC=C1N1C(=O)OCC1 DCOQTEQWWQSBAB-NSHDSACASA-N 0.000 claims description 2
- BYKUXOPPKXTQRJ-NSHDSACASA-N n-[[(5s)-2-oxo-3-[4-(2-oxo-1,3-oxazolidin-3-yl)-3-(trifluoromethyl)phenyl]-1,3-oxazolidin-5-yl]methyl]prop-2-enamide Chemical compound FC(F)(F)C1=CC(N2C(O[C@@H](CNC(=O)C=C)C2)=O)=CC=C1N1CCOC1=O BYKUXOPPKXTQRJ-NSHDSACASA-N 0.000 claims description 2
- TUTAUJDFYAHIJQ-NSHDSACASA-N n-[[(5s)-2-oxo-3-[4-(2-oxo-1,3-oxazolidin-3-yl)-3-(trifluoromethyl)phenyl]-1,3-oxazolidin-5-yl]methyl]propanamide Chemical compound O=C1O[C@@H](CNC(=O)CC)CN1C(C=C1C(F)(F)F)=CC=C1N1C(=O)OCC1 TUTAUJDFYAHIJQ-NSHDSACASA-N 0.000 claims description 2
- DONMUZMETWDXCJ-UEWDXFNNSA-N n-[[(5s)-2-oxo-3-[4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-1,3-oxazolidin-5-yl]-(2,2,2-trifluoroethoxy)methyl]methanethioamide Chemical compound O=C1O[C@H](C(NC=S)OCC(F)(F)F)CN1C1=CC=C(N2C(OCC2)=O)C=C1 DONMUZMETWDXCJ-UEWDXFNNSA-N 0.000 claims description 2
- GPACZPWLHOILID-VYRBHSGPSA-N n-[[(5s)-2-oxo-3-[4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-1,3-oxazolidin-5-yl]-thiomorpholin-4-ylmethyl]methanethioamide Chemical compound O=C1OCCN1C1=CC=C(N2C(O[C@@H](C2)C(NC=S)N2CCSCC2)=O)C=C1 GPACZPWLHOILID-VYRBHSGPSA-N 0.000 claims description 2
- SAAVZMFDWFPECV-ZDUSSCGKSA-N n-[[(5s)-2-oxo-3-[4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-1,3-oxazolidin-5-yl]methyl]acetamide Chemical compound O=C1O[C@@H](CNC(=O)C)CN1C1=CC=C(N2C(OCC2)=O)C=C1 SAAVZMFDWFPECV-ZDUSSCGKSA-N 0.000 claims description 2
- HHKOTYAQIYFYBG-ZDUSSCGKSA-N n-[[(5s)-2-oxo-3-[4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-1,3-oxazolidin-5-yl]methyl]ethanethioamide Chemical compound O=C1O[C@@H](CNC(=S)C)CN1C1=CC=C(N2C(OCC2)=O)C=C1 HHKOTYAQIYFYBG-ZDUSSCGKSA-N 0.000 claims description 2
- QMXKYWAEUWNOLQ-ZDUSSCGKSA-N n-[[(5s)-2-oxo-3-[4-(2-sulfanylidene-1,3-oxazolidin-3-yl)phenyl]-1,3-oxazolidin-5-yl]methyl]acetamide Chemical compound O=C1O[C@@H](CNC(=O)C)CN1C1=CC=C(N2C(OCC2)=S)C=C1 QMXKYWAEUWNOLQ-ZDUSSCGKSA-N 0.000 claims description 2
- OJHAZXKLQOVZKF-NSHDSACASA-N n-[[(5s)-3-[2-fluoro-4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide Chemical compound O=C1O[C@@H](CNC(=O)C)CN1C1=CC=C(N2C(OCC2)=O)C=C1F OJHAZXKLQOVZKF-NSHDSACASA-N 0.000 claims description 2
- VBMXGKCKHFZJAN-JTQLQIEISA-N n-[[(5s)-3-[3,5-difluoro-4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide Chemical compound O=C1O[C@@H](CNC(=O)C)CN1C(C=C1F)=CC(F)=C1N1C(=O)OCC1 VBMXGKCKHFZJAN-JTQLQIEISA-N 0.000 claims description 2
- GPVNIESOLQKJJF-JTQLQIEISA-N n-[[(5s)-3-[3,5-difluoro-4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]ethanethioamide Chemical compound O=C1O[C@@H](CNC(=S)C)CN1C(C=C1F)=CC(F)=C1N1C(=O)OCC1 GPVNIESOLQKJJF-JTQLQIEISA-N 0.000 claims description 2
- HICDUNUQCFLQBB-VIFPVBQESA-N n-[[(5s)-3-[3,5-difluoro-4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]formamide Chemical compound FC1=CC(N2C(O[C@@H](CNC=O)C2)=O)=CC(F)=C1N1CCOC1=O HICDUNUQCFLQBB-VIFPVBQESA-N 0.000 claims description 2
- ZFUOXOUFJFNDAU-JTQLQIEISA-N n-[[(5s)-3-[3,5-difluoro-4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]propanamide Chemical compound O=C1O[C@@H](CNC(=O)CC)CN1C(C=C1F)=CC(F)=C1N1C(=O)OCC1 ZFUOXOUFJFNDAU-JTQLQIEISA-N 0.000 claims description 2
- FWBGGMRUKIISSM-JTQLQIEISA-N n-[[(5s)-3-[3,5-difluoro-4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]propanethioamide Chemical compound O=C1O[C@@H](CNC(=S)CC)CN1C(C=C1F)=CC(F)=C1N1C(=O)OCC1 FWBGGMRUKIISSM-JTQLQIEISA-N 0.000 claims description 2
- OUXWNALHZWITPU-ZDUSSCGKSA-N n-[[(5s)-3-[3-fluoro-4-(2-oxo-1,3-benzoxazol-3-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide Chemical compound O=C1O[C@@H](CNC(=O)C)CN1C1=CC=C(N2C(OC3=CC=CC=C32)=O)C(F)=C1 OUXWNALHZWITPU-ZDUSSCGKSA-N 0.000 claims description 2
- BSGRZZDQXJMOJA-NSHDSACASA-N n-[[(5s)-3-[3-fluoro-4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide Chemical compound O=C1O[C@@H](CNC(=O)C)CN1C(C=C1F)=CC=C1N1C(=O)OCC1 BSGRZZDQXJMOJA-NSHDSACASA-N 0.000 claims description 2
- XWJIZTGLGRHGPN-LBPRGKRZSA-N n-[[(5s)-3-[3-fluoro-4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]butanamide Chemical compound O=C1O[C@@H](CNC(=O)CCC)CN1C(C=C1F)=CC=C1N1C(=O)OCC1 XWJIZTGLGRHGPN-LBPRGKRZSA-N 0.000 claims description 2
- PDXRYOZTTDVMOC-NSHDSACASA-N n-[[(5s)-3-[3-fluoro-4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]ethanethioamide Chemical compound O=C1O[C@@H](CNC(=S)C)CN1C(C=C1F)=CC=C1N1C(=O)OCC1 PDXRYOZTTDVMOC-NSHDSACASA-N 0.000 claims description 2
- PPFRJJNAUIDSFO-JTQLQIEISA-N n-[[(5s)-3-[3-fluoro-4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]formamide Chemical compound FC1=CC(N2C(O[C@@H](CNC=O)C2)=O)=CC=C1N1CCOC1=O PPFRJJNAUIDSFO-JTQLQIEISA-N 0.000 claims description 2
- KLERNSIVAUASCY-HNNXBMFYSA-N n-[[(5s)-3-[3-fluoro-4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]heptanamide Chemical compound O=C1O[C@@H](CNC(=O)CCCCCC)CN1C(C=C1F)=CC=C1N1C(=O)OCC1 KLERNSIVAUASCY-HNNXBMFYSA-N 0.000 claims description 2
- UJECIDDUVQIHED-ZDUSSCGKSA-N n-[[(5s)-3-[3-fluoro-4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]pentanamide Chemical compound O=C1O[C@@H](CNC(=O)CCCC)CN1C(C=C1F)=CC=C1N1C(=O)OCC1 UJECIDDUVQIHED-ZDUSSCGKSA-N 0.000 claims description 2
- JZUFKJITPSOJLH-NSHDSACASA-N n-[[(5s)-3-[3-fluoro-4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]prop-2-enamide Chemical compound FC1=CC(N2C(O[C@@H](CNC(=O)C=C)C2)=O)=CC=C1N1CCOC1=O JZUFKJITPSOJLH-NSHDSACASA-N 0.000 claims description 2
- HVTTVYRIJMSUPF-NSHDSACASA-N n-[[(5s)-3-[3-fluoro-4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]propanamide Chemical compound O=C1O[C@@H](CNC(=O)CC)CN1C(C=C1F)=CC=C1N1C(=O)OCC1 HVTTVYRIJMSUPF-NSHDSACASA-N 0.000 claims description 2
- UVOAHHKBBZCZKF-KRWDZBQOSA-N n-[[(5s)-3-[3-fluoro-4-(2-oxo-3-phenylimidazolidin-1-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide Chemical compound O=C1O[C@@H](CNC(=O)C)CN1C(C=C1F)=CC=C1N1C(=O)N(C=2C=CC=CC=2)CC1 UVOAHHKBBZCZKF-KRWDZBQOSA-N 0.000 claims description 2
- NGZTXIMPNRSEKY-NSHDSACASA-N n-[[(5s)-3-[3-fluoro-4-(2-sulfanylidene-1,3-oxazolidin-3-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide Chemical compound O=C1O[C@@H](CNC(=O)C)CN1C(C=C1F)=CC=C1N1C(=S)OCC1 NGZTXIMPNRSEKY-NSHDSACASA-N 0.000 claims description 2
- GDNXYPAJKULNKA-NSHDSACASA-N n-[[(5s)-3-[3-fluoro-4-(2-sulfanylidene-1,3-thiazolidin-3-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide Chemical compound O=C1O[C@@H](CNC(=O)C)CN1C(C=C1F)=CC=C1N1C(=S)SCC1 GDNXYPAJKULNKA-NSHDSACASA-N 0.000 claims description 2
- QJTQLQQCMPPXIX-LBPRGKRZSA-N n-[[(5s)-3-[3-fluoro-4-(3-methyl-2-oxoimidazolidin-1-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide Chemical compound O=C1N(C)CCN1C1=CC=C(N2C(O[C@@H](CNC(C)=O)C2)=O)C=C1F QJTQLQQCMPPXIX-LBPRGKRZSA-N 0.000 claims description 2
- ZTYUCAGUOAVOCG-LBPRGKRZSA-N n-[[(5s)-3-[3-fluoro-4-(3-methyl-2-sulfanylideneimidazolidin-1-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide Chemical compound S=C1N(C)CCN1C1=CC=C(N2C(O[C@@H](CNC(C)=O)C2)=O)C=C1F ZTYUCAGUOAVOCG-LBPRGKRZSA-N 0.000 claims description 2
- QHJZGZQOGRGISM-LBPRGKRZSA-N n-[[(5s)-3-[3-fluoro-4-(3-methyl-2-sulfanylideneimidazolidin-1-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]ethanethioamide Chemical compound S=C1N(C)CCN1C1=CC=C(N2C(O[C@@H](CNC(C)=S)C2)=O)C=C1F QHJZGZQOGRGISM-LBPRGKRZSA-N 0.000 claims description 2
- SRVLYUMAWSUPOZ-LBPRGKRZSA-N n-[[(5s)-3-[3-fluoro-4-(3-methyl-4-oxoimidazolidin-1-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide Chemical compound C1C(=O)N(C)CN1C1=CC=C(N2C(O[C@@H](CNC(C)=O)C2)=O)C=C1F SRVLYUMAWSUPOZ-LBPRGKRZSA-N 0.000 claims description 2
- JMWLIUDYAWSYNE-LBPRGKRZSA-N n-[[(5s)-3-[3-fluoro-4-(3-methyl-4-oxoimidazolidin-1-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]ethanethioamide Chemical compound C1C(=O)N(C)CN1C1=CC=C(N2C(O[C@@H](CNC(C)=S)C2)=O)C=C1F JMWLIUDYAWSYNE-LBPRGKRZSA-N 0.000 claims description 2
- GSNJCUXZBQBDKD-KRWDZBQOSA-N n-[[(5s)-3-[3-fluoro-4-[3-(4-fluorophenyl)-2-oxoimidazolidin-1-yl]phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide Chemical compound O=C1O[C@@H](CNC(=O)C)CN1C(C=C1F)=CC=C1N1C(=O)N(C=2C=CC(F)=CC=2)CC1 GSNJCUXZBQBDKD-KRWDZBQOSA-N 0.000 claims description 2
- IAOBXRUJPCCRQZ-FQEVSTJZSA-N n-[[(5s)-3-[4-(3-benzyl-2-oxoimidazolidin-1-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide Chemical compound O=C1O[C@@H](CNC(=O)C)CN1C1=CC=C(N2C(N(CC=3C=CC=CC=3)CC2)=O)C=C1 IAOBXRUJPCCRQZ-FQEVSTJZSA-N 0.000 claims description 2
- TWAFVIDWSSCIDY-SFHVURJKSA-N n-[[(5s)-3-[4-(3-benzyl-4-oxoimidazolidin-1-yl)-3-fluorophenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide Chemical compound O=C1O[C@@H](CNC(=O)C)CN1C(C=C1F)=CC=C1N1CC(=O)N(CC=2C=CC=CC=2)C1 TWAFVIDWSSCIDY-SFHVURJKSA-N 0.000 claims description 2
- DJXDARFOMVOEQB-AWEZNQCLSA-N n-[[(5s)-3-[4-(3-methyl-2-oxoimidazolidin-1-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide Chemical compound O=C1N(C)CCN1C1=CC=C(N2C(O[C@@H](CNC(C)=O)C2)=O)C=C1 DJXDARFOMVOEQB-AWEZNQCLSA-N 0.000 claims description 2
- XOOVLDXDHKQPCR-UHFFFAOYSA-N o-propan-2-yl carbamothioate Chemical compound CC(C)OC(N)=S XOOVLDXDHKQPCR-UHFFFAOYSA-N 0.000 claims description 2
- 125000003545 alkoxy group Chemical group 0.000 claims 17
- 229910052736 halogen Inorganic materials 0.000 claims 16
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 15
- 125000000217 alkyl group Chemical group 0.000 claims 15
- 125000003118 aryl group Chemical group 0.000 claims 15
- 150000002367 halogens Chemical class 0.000 claims 15
- 125000001424 substituent group Chemical group 0.000 claims 14
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 13
- 125000004093 cyano group Chemical group *C#N 0.000 claims 12
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 11
- 229910052739 hydrogen Inorganic materials 0.000 claims 10
- 239000001257 hydrogen Substances 0.000 claims 10
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims 9
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims 8
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims 8
- 125000005843 halogen group Chemical group 0.000 claims 8
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 8
- 125000002252 acyl group Chemical group 0.000 claims 7
- 125000004104 aryloxy group Chemical group 0.000 claims 7
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 6
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 claims 6
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 claims 6
- 125000004423 acyloxy group Chemical group 0.000 claims 6
- 125000003282 alkyl amino group Chemical group 0.000 claims 6
- 229940024606 amino acid Drugs 0.000 claims 6
- 235000001014 amino acid Nutrition 0.000 claims 6
- 150000001413 amino acids Chemical class 0.000 claims 6
- 125000003710 aryl alkyl group Chemical group 0.000 claims 6
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 claims 6
- 125000000753 cycloalkyl group Chemical group 0.000 claims 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N monobenzene Natural products C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims 6
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 5
- 125000005161 aryl oxy carbonyl group Chemical group 0.000 claims 5
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 claims 4
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 claims 4
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims 4
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 4
- 125000004739 (C1-C6) alkylsulfonyl group Chemical group 0.000 claims 3
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 3
- GVNVAWHJIKLAGL-UHFFFAOYSA-N 2-(cyclohexen-1-yl)cyclohexan-1-one Chemical compound O=C1CCCCC1C1=CCCCC1 GVNVAWHJIKLAGL-UHFFFAOYSA-N 0.000 claims 3
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims 3
- 101150065749 Churc1 gene Proteins 0.000 claims 3
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical class NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 claims 3
- 102100038239 Protein Churchill Human genes 0.000 claims 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims 3
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims 3
- 125000001769 aryl amino group Chemical group 0.000 claims 3
- 125000005129 aryl carbonyl group Chemical group 0.000 claims 3
- 150000001555 benzenes Chemical class 0.000 claims 3
- 125000004432 carbon atom Chemical group C* 0.000 claims 3
- CWJSHJJYOPWUGX-UHFFFAOYSA-N chlorpropham Chemical compound CC(C)OC(=O)NC1=CC=CC(Cl)=C1 CWJSHJJYOPWUGX-UHFFFAOYSA-N 0.000 claims 3
- 125000004475 heteroaralkyl group Chemical group 0.000 claims 3
- 125000001072 heteroaryl group Chemical group 0.000 claims 3
- 125000000623 heterocyclic group Chemical group 0.000 claims 3
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 3
- 229910052760 oxygen Inorganic materials 0.000 claims 3
- VXPLXMJHHKHSOA-UHFFFAOYSA-N propham Chemical compound CC(C)OC(=O)NC1=CC=CC=C1 VXPLXMJHHKHSOA-UHFFFAOYSA-N 0.000 claims 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims 3
- 239000012453 solvate Substances 0.000 claims 3
- 229910052717 sulfur Inorganic materials 0.000 claims 3
- 229930192474 thiophene Natural products 0.000 claims 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 2
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Chemical class CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 claims 2
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 claims 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims 2
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Chemical class CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 claims 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims 2
- 150000002357 guanidines Chemical class 0.000 claims 2
- ZBKFYXZXZJPWNQ-UHFFFAOYSA-N isothiocyanate group Chemical group [N-]=C=S ZBKFYXZXZJPWNQ-UHFFFAOYSA-N 0.000 claims 2
- 150000007530 organic bases Chemical class 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 claims 2
- YAPQBXQYLJRXSA-UHFFFAOYSA-N theobromine Chemical compound CN1C(=O)NC(=O)C2=C1N=CN2C YAPQBXQYLJRXSA-UHFFFAOYSA-N 0.000 claims 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims 1
- SUAHEWOAWXRFMO-SECBINFHSA-N (5r)-5-(aminomethyl)-3-[4-(2-oxo-1,3-oxazolidin-3-yl)-3-(trifluoromethyl)phenyl]-1,3-oxazolidin-2-one Chemical compound O=C1O[C@H](CN)CN1C(C=C1C(F)(F)F)=CC=C1N1C(=O)OCC1 SUAHEWOAWXRFMO-SECBINFHSA-N 0.000 claims 1
- QBJWFDSSCNNXBM-SECBINFHSA-N (5r)-5-(hydroxymethyl)-3-[4-(2-oxo-1,3-oxazolidin-3-yl)-3-(trifluoromethyl)phenyl]-1,3-oxazolidin-2-one Chemical compound O=C1O[C@@H](CO)CN1C(C=C1C(F)(F)F)=CC=C1N1C(=O)OCC1 QBJWFDSSCNNXBM-SECBINFHSA-N 0.000 claims 1
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims 1
- 125000006529 (C3-C6) alkyl group Chemical group 0.000 claims 1
- HMBHAQMOBKLWRX-UHFFFAOYSA-N 2,3-dihydro-1,4-benzodioxine-3-carboxylic acid Chemical compound C1=CC=C2OC(C(=O)O)COC2=C1 HMBHAQMOBKLWRX-UHFFFAOYSA-N 0.000 claims 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 claims 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 claims 1
- MWGATWIBSKHFMR-UHFFFAOYSA-N 2-anilinoethanol Chemical compound OCCNC1=CC=CC=C1 MWGATWIBSKHFMR-UHFFFAOYSA-N 0.000 claims 1
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 claims 1
- 229940013085 2-diethylaminoethanol Drugs 0.000 claims 1
- UPHOPMSGKZNELG-UHFFFAOYSA-N 2-hydroxynaphthalene-1-carboxylic acid Chemical class C1=CC=C2C(C(=O)O)=C(O)C=CC2=C1 UPHOPMSGKZNELG-UHFFFAOYSA-N 0.000 claims 1
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical class OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 claims 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical class [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims 1
- 239000004475 Arginine Substances 0.000 claims 1
- 208000035143 Bacterial infection Diseases 0.000 claims 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 claims 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims 1
- XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical compound C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 claims 1
- 239000004471 Glycine Substances 0.000 claims 1
- QMXOFBXZEKTJIK-UHFFFAOYSA-N Glycinol Natural products C1=C(O)C=C2OCC3(O)C4=CC=C(O)C=C4OC3C2=C1 QMXOFBXZEKTJIK-UHFFFAOYSA-N 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 claims 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 claims 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims 1
- 150000000994 L-ascorbates Chemical class 0.000 claims 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 claims 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims 1
- LRQKBLKVPFOOQJ-YFKPBYRVSA-N L-norleucine Chemical compound CCCC[C@H]([NH3+])C([O-])=O LRQKBLKVPFOOQJ-YFKPBYRVSA-N 0.000 claims 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 1
- 239000004472 Lysine Substances 0.000 claims 1
- UEEJHVSXFDXPFK-UHFFFAOYSA-N N-dimethylaminoethanol Chemical compound CN(C)CCO UEEJHVSXFDXPFK-UHFFFAOYSA-N 0.000 claims 1
- HTLZVHNRZJPSMI-UHFFFAOYSA-N N-ethylpiperidine Chemical compound CCN1CCCCC1 HTLZVHNRZJPSMI-UHFFFAOYSA-N 0.000 claims 1
- 229910002651 NO3 Inorganic materials 0.000 claims 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 claims 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 claims 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 claims 1
- 229910019142 PO4 Inorganic materials 0.000 claims 1
- BHHGXPLMPWCGHP-UHFFFAOYSA-N Phenethylamine Chemical compound NCCC1=CC=CC=C1 BHHGXPLMPWCGHP-UHFFFAOYSA-N 0.000 claims 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 claims 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims 1
- 239000004473 Threonine Substances 0.000 claims 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims 1
- 230000000397 acetylating effect Effects 0.000 claims 1
- 235000004279 alanine Nutrition 0.000 claims 1
- 125000005090 alkenylcarbonyl group Chemical group 0.000 claims 1
- 125000003302 alkenyloxy group Chemical group 0.000 claims 1
- 125000005092 alkenyloxycarbonyl group Chemical group 0.000 claims 1
- 125000004171 alkoxy aryl group Chemical group 0.000 claims 1
- 125000004685 alkoxythiocarbonyl group Chemical group 0.000 claims 1
- 125000000304 alkynyl group Chemical group 0.000 claims 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 claims 1
- 150000003927 aminopyridines Chemical class 0.000 claims 1
- 150000005005 aminopyrimidines Chemical class 0.000 claims 1
- 150000003863 ammonium salts Chemical class 0.000 claims 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 1
- 235000010323 ascorbic acid Nutrition 0.000 claims 1
- 150000001540 azides Chemical class 0.000 claims 1
- 208000022362 bacterial infectious disease Diseases 0.000 claims 1
- JUHORIMYRDESRB-UHFFFAOYSA-N benzathine Chemical compound C=1C=CC=CC=1CNCCNCC1=CC=CC=C1 JUHORIMYRDESRB-UHFFFAOYSA-N 0.000 claims 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical class OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 claims 1
- 150000001558 benzoic acid derivatives Chemical class 0.000 claims 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 claims 1
- 229960003237 betaine Drugs 0.000 claims 1
- 229960001948 caffeine Drugs 0.000 claims 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims 1
- 229960001231 choline Drugs 0.000 claims 1
- 229940075419 choline hydroxide Drugs 0.000 claims 1
- 229910052802 copper Inorganic materials 0.000 claims 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims 1
- 235000018417 cysteine Nutrition 0.000 claims 1
- 229960003067 cystine Drugs 0.000 claims 1
- 125000004663 dialkyl amino group Chemical group 0.000 claims 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 claims 1
- 229940043237 diethanolamine Drugs 0.000 claims 1
- HRKQOINLCJTGBK-UHFFFAOYSA-N dihydroxidosulfur Chemical compound OSO HRKQOINLCJTGBK-UHFFFAOYSA-N 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 229940012017 ethylenediamine Drugs 0.000 claims 1
- 229910052731 fluorine Inorganic materials 0.000 claims 1
- 239000011737 fluorine Substances 0.000 claims 1
- 229960002442 glucosamine Drugs 0.000 claims 1
- 150000002315 glycerophosphates Chemical class 0.000 claims 1
- 150000004820 halides Chemical class 0.000 claims 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 claims 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims 1
- XGIHQYAWBCFNPY-AZOCGYLKSA-N hydrabamine Chemical compound C([C@@H]12)CC3=CC(C(C)C)=CC=C3[C@@]2(C)CCC[C@@]1(C)CNCCNC[C@@]1(C)[C@@H]2CCC3=CC(C(C)C)=CC=C3[C@@]2(C)CCC1 XGIHQYAWBCFNPY-AZOCGYLKSA-N 0.000 claims 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 1
- 125000005027 hydroxyaryl group Chemical group 0.000 claims 1
- 229960002591 hydroxyproline Drugs 0.000 claims 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims 1
- 229960000310 isoleucine Drugs 0.000 claims 1
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 claims 1
- 150000002540 isothiocyanates Chemical class 0.000 claims 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 claims 1
- 229960003194 meglumine Drugs 0.000 claims 1
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 claims 1
- 229960003105 metformin Drugs 0.000 claims 1
- 229930182817 methionine Natural products 0.000 claims 1
- NOUUUQMKVOUUNR-UHFFFAOYSA-N n,n'-diphenylethane-1,2-diamine Chemical compound C=1C=CC=CC=1NCCNC1=CC=CC=C1 NOUUUQMKVOUUNR-UHFFFAOYSA-N 0.000 claims 1
- WNYIBZHOMJZDKN-UHFFFAOYSA-N n-(2-acetamidoethyl)acetamide Chemical compound CC(=O)NCCNC(C)=O WNYIBZHOMJZDKN-UHFFFAOYSA-N 0.000 claims 1
- TWSIYKCFPPZWOL-HNNXBMFYSA-N n-[[(5s)-2-oxo-3-[4-(2-oxo-1,3-oxazolidin-3-yl)-3-(trifluoromethyl)phenyl]-1,3-oxazolidin-5-yl]methyl]heptanamide Chemical compound O=C1O[C@@H](CNC(=O)CCCCCC)CN1C(C=C1C(F)(F)F)=CC=C1N1C(=O)OCC1 TWSIYKCFPPZWOL-HNNXBMFYSA-N 0.000 claims 1
- BXWXOMYIEPEBDZ-MYJWUSKBSA-N n-[[(5s)-2-oxo-3-[4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-1,3-oxazolidin-5-yl]-(pyridin-2-ylamino)methyl]methanethioamide Chemical compound O=C1OCCN1C1=CC=C(N2C(O[C@@H](C2)C(NC=S)NC=2N=CC=CC=2)=O)C=C1 BXWXOMYIEPEBDZ-MYJWUSKBSA-N 0.000 claims 1
- ULXQVKWBHYXHHU-ZENAZSQFSA-N n-[[(5s)-2-oxo-3-[4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-1,3-oxazolidin-5-yl]-(pyridin-2-ylmethylamino)methyl]methanethioamide Chemical compound O=C1OCCN1C1=CC=C(N2C(O[C@@H](C2)C(NCC=2N=CC=CC=2)NC=S)=O)C=C1 ULXQVKWBHYXHHU-ZENAZSQFSA-N 0.000 claims 1
- NXVJUNKFDJVOAX-LBPRGKRZSA-N n-[[(5s)-3-[3-fluoro-4-(3-methyl-2-oxoimidazolidin-1-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]ethanethioamide Chemical compound O=C1N(C)CCN1C1=CC=C(N2C(O[C@@H](CNC(C)=S)C2)=O)C=C1F NXVJUNKFDJVOAX-LBPRGKRZSA-N 0.000 claims 1
- 229960003104 ornithine Drugs 0.000 claims 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-M perchlorate Inorganic materials [O-]Cl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-M 0.000 claims 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 1
- 239000010452 phosphate Substances 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 claims 1
- 229960004919 procaine Drugs 0.000 claims 1
- 125000004076 pyridyl group Chemical group 0.000 claims 1
- 150000003873 salicylate salts Chemical class 0.000 claims 1
- 239000000243 solution Substances 0.000 claims 1
- 229940063673 spermidine Drugs 0.000 claims 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
- 239000006188 syrup Substances 0.000 claims 1
- 235000020357 syrup Nutrition 0.000 claims 1
- 239000003826 tablet Substances 0.000 claims 1
- 229940095064 tartrate Drugs 0.000 claims 1
- 229960004559 theobromine Drugs 0.000 claims 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 claims 1
- 229960003495 thiamine Drugs 0.000 claims 1
- 235000019157 thiamine Nutrition 0.000 claims 1
- 239000011721 thiamine Substances 0.000 claims 1
- 125000003441 thioacyl group Chemical group 0.000 claims 1
- ZWZVWGITAAIFPS-UHFFFAOYSA-N thiophosgene Chemical compound ClC(Cl)=S ZWZVWGITAAIFPS-UHFFFAOYSA-N 0.000 claims 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 claims 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims 1
- 125000005270 trialkylamine group Chemical group 0.000 claims 1
- YFTHZRPMJXBUME-UHFFFAOYSA-N tripropylamine Chemical compound CCCN(CCC)CCC YFTHZRPMJXBUME-UHFFFAOYSA-N 0.000 claims 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims 1
- 229960000281 trometamol Drugs 0.000 claims 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims 1
- 239000004474 valine Substances 0.000 claims 1
- 229910052725 zinc Inorganic materials 0.000 claims 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- GSTGCXIFAFUZHT-SECBINFHSA-N (5r)-3-[3-fluoro-4-(2-sulfanylidene-1,3-thiazolidin-3-yl)phenyl]-5-(hydroxymethyl)-1,3-oxazolidin-2-one Chemical compound O=C1O[C@@H](CO)CN1C(C=C1F)=CC=C1N1C(=S)SCC1 GSTGCXIFAFUZHT-SECBINFHSA-N 0.000 description 1
- GGXCJVHQWCDDSN-BHWOMJMDSA-N C1COC(=O)N1C2=CC=C(C=C2)N3C[C@H](OC3=O)C(C4=CC=CC=N4)NC=S Chemical compound C1COC(=O)N1C2=CC=C(C=C2)N3C[C@H](OC3=O)C(C4=CC=CC=N4)NC=S GGXCJVHQWCDDSN-BHWOMJMDSA-N 0.000 description 1
- POSCEOZJLWACHU-OYKVQYDMSA-N C1COC(=O)N1C2=CC=C(C=C2)N3C[C@H](OC3=O)C(NCCC4=CC=CC=N4)NC=S Chemical compound C1COC(=O)N1C2=CC=C(C=C2)N3C[C@H](OC3=O)C(NCCC4=CC=CC=N4)NC=S POSCEOZJLWACHU-OYKVQYDMSA-N 0.000 description 1
- AYZGDUQXJAZJEQ-UHFFFAOYSA-N O-ethyl carbamothioate hydrochloride Chemical compound CCOC(=S)N.Cl AYZGDUQXJAZJEQ-UHFFFAOYSA-N 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- JLZGAASRVRHKQH-NSHDSACASA-N n-[[(5s)-2-oxo-3-[4-(2-oxo-1,3-oxazolidin-3-yl)-3-(trifluoromethyl)phenyl]-1,3-oxazolidin-5-yl]methyl]ethanethioamide Chemical compound O=C1O[C@@H](CNC(=S)C)CN1C(C=C1C(F)(F)F)=CC=C1N1C(=O)OCC1 JLZGAASRVRHKQH-NSHDSACASA-N 0.000 description 1
- SGDHCJZYIINEIF-KRWDZBQOSA-N n-[[(5s)-3-[3-fluoro-4-(2-oxo-3-phenylimidazolidin-1-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]ethanethioamide Chemical compound O=C1O[C@@H](CNC(=S)C)CN1C(C=C1F)=CC=C1N1C(=O)N(C=2C=CC=CC=2)CC1 SGDHCJZYIINEIF-KRWDZBQOSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1124MA2000 | 2000-12-26 | ||
| IN15MA2001 | 2001-01-15 | ||
| PCT/IN2001/000227 WO2002051819A2 (en) | 2000-12-26 | 2001-12-26 | Heterocyclic compounds having antibacterial activity, process for their preparation and pharmaceutical compositions containing them |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004525876A JP2004525876A (ja) | 2004-08-26 |
| JP2004525876A5 true JP2004525876A5 (enExample) | 2005-12-22 |
Family
ID=26324889
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002552914A Withdrawn JP2004525876A (ja) | 2000-12-26 | 2001-12-26 | 抗細菌活性を有する新規複素環式化合物、それらの調製方法、およびそれらを含有する薬学的組成物 |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US7030148B2 (enExample) |
| EP (1) | EP1345913A2 (enExample) |
| JP (1) | JP2004525876A (enExample) |
| KR (1) | KR20030063472A (enExample) |
| CN (1) | CN1656083A (enExample) |
| BG (1) | BG108022A (enExample) |
| BR (1) | BR0116571A (enExample) |
| CA (1) | CA2433138A1 (enExample) |
| CZ (1) | CZ20031799A3 (enExample) |
| EE (1) | EE200300254A (enExample) |
| HR (1) | HRP20030522A2 (enExample) |
| HU (1) | HUP0302580A2 (enExample) |
| IL (1) | IL156662A0 (enExample) |
| MX (1) | MXPA03005822A (enExample) |
| NO (1) | NO20032926L (enExample) |
| NZ (1) | NZ526716A (enExample) |
| PL (1) | PL363616A1 (enExample) |
| RU (1) | RU2322444C2 (enExample) |
| SK (1) | SK8202003A3 (enExample) |
| WO (1) | WO2002051819A2 (enExample) |
| YU (1) | YU52403A (enExample) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9928568D0 (en) | 1999-12-03 | 2000-02-02 | Zeneca Ltd | Chemical compounds |
| GB0009803D0 (en) | 2000-04-25 | 2000-06-07 | Astrazeneca Ab | Chemical compounds |
| AU2002329393B2 (en) | 2001-09-11 | 2008-06-12 | Astrazeneca Ab | Oxazolidinone and/or isoxazoline as antibacterial agents |
| US20060293315A1 (en) * | 2001-12-21 | 2006-12-28 | Dr. Reddy's Laboratories Ltd. | Intermediates of novel heterocyclic compounds having antibacterial activity and process for their preparation |
| US6914058B2 (en) * | 2002-01-18 | 2005-07-05 | Dr. Reddy's Laboratories, Limited | Antibacterial compounds: process for their preparation and pharmaceutical compositions containing them |
| US7141561B2 (en) | 2002-07-25 | 2006-11-28 | Sanofi-Aventis Deutschland Gmbh | Substituted diaryl heterocycles, process for their preparation and their use as medicaments |
| DE10233817A1 (de) * | 2002-07-25 | 2004-02-12 | Aventis Pharma Deutschland Gmbh | Substituierte Diarylheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| AU2003215861A1 (en) * | 2003-04-07 | 2004-11-01 | Ranbaxy Laboratories Limited | Oxazolidinone derivatives as antimicrobials |
| AU2004256085B2 (en) * | 2003-07-02 | 2007-12-06 | Kyorin, Pharmaceutical Co., Ltd. | Cyclopropyl Group Substituted Oxazolydinone Antibiotics and Derivatives Thereof |
| MXPA06000228A (es) | 2003-07-02 | 2006-06-27 | Merck & Co Inc | Antibioticos de oxazolidinona sustituidos con un grupo ciclopropilo y derivados de los mismos. |
| WO2005035528A2 (en) * | 2003-10-14 | 2005-04-21 | Dr. Reddy's Laboratories Ltd. | Triazole derivatives as antibacterial agents |
| KR100854211B1 (ko) | 2003-12-18 | 2008-08-26 | 동아제약주식회사 | 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물 |
| WO2006091731A2 (en) * | 2005-02-24 | 2006-08-31 | Teva Pharmaceutical Industries Ltd. | Processes for the preparation of linezolid intermediate |
| AP2007004244A0 (en) | 2005-05-10 | 2007-12-31 | Intermune Inc | Method of modulating stress-activated protein kinase system |
| CN101720325B (zh) * | 2007-08-06 | 2013-04-24 | 上海盟科药业有限公司 | 用于治疗细菌感染的抗菌邻-氟苯基噁唑烷酮 |
| EP2296653B1 (en) | 2008-06-03 | 2016-01-27 | Intermune, Inc. | Compounds and methods for treating inflammatory and fibrotic disorders |
| US9643922B2 (en) | 2008-08-18 | 2017-05-09 | Yale University | MIF modulators |
| MX2011001872A (es) * | 2008-08-18 | 2011-05-23 | Univ Yale | Moduladores de mif. |
| US9540322B2 (en) | 2008-08-18 | 2017-01-10 | Yale University | MIF modulators |
| MX384300B (es) | 2009-02-03 | 2025-03-14 | Merck Sharp & Dohme Llc | Forma cristalina del fosfato de dihidrogeno r) -3- (4- (2- (2-metiltetrazol-5-il) piridin-5-il) -3-fluorofenil) -5-hidroximetil oxazolidin-2-ona. |
| CN101798302B (zh) * | 2009-02-06 | 2014-11-05 | 上海盟科药业有限公司 | 抗生素类药物1-(邻-氟苯基)二氢吡啶酮的合成及生产的方法和工艺 |
| WO2014045292A1 (en) * | 2012-09-20 | 2014-03-27 | Symed Labs Limited | Improved process for the preparation of linezolid intermediate |
| AR092742A1 (es) | 2012-10-02 | 2015-04-29 | Intermune Inc | Piridinonas antifibroticas |
| WO2015127316A1 (en) | 2014-02-21 | 2015-08-27 | Micurx Pharmaceuticals, Inc. | Water-soluble o-carbonyl phosphoramidate prodrugs for therapeutic administration |
| RU2692485C2 (ru) | 2014-04-02 | 2019-06-25 | Интермьюн, Инк. | Противофиброзные пиридиноны |
| GB2550437B (en) * | 2016-05-20 | 2021-06-23 | Bugworks Res Inc | Heterocyclic compounds useful as anti-bacterial agents and method for production |
| US12109203B2 (en) | 2018-07-25 | 2024-10-08 | Zydus Lifesciences Limited | Substituted oxazolidinones for the treatment of mammalian infections |
| WO2020234636A1 (en) | 2019-05-17 | 2020-11-26 | Cadila Healthcare Limited | Novel compounds for the treatment of mammalian infections |
| CN110301433A (zh) * | 2019-07-25 | 2019-10-08 | 河南精怡达生物科技有限公司 | 一种含有微量元素组合的猪精液体外常温保存剂 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2987505A (en) * | 1958-03-04 | 1961-06-06 | Gen Aniline & Film Corp | Compositions of polymeric nu-vinyl-2-oxazolidone and halogens |
| US3651079A (en) | 1968-11-25 | 1972-03-21 | Colgate Palmolive Co | 1-aryl-5-hydroxyalkyl-hydantoins |
| GB1408010A (en) * | 1972-11-20 | 1975-10-01 | Geistlich Soehne Ag | Sulphamoylphenyl-imidazolidinones |
| US4174958A (en) | 1978-01-09 | 1979-11-20 | Shell Oil Company | Anilide derivative herbicides |
| FR2571364B1 (fr) * | 1984-10-09 | 1987-07-17 | Oreal | Nouveau procede de preparation de nitroparaphenylenediamines n,n'-disubstituees, nouvelles oxazolidones utilisees dans ce procede, nouvelles nitroparaphenylenediamines n,n'-disubstituees obtenues selon ce procede et compositions tinctoriales contenant les nitroparaphenylenediamines n,n'-disubstituees obtenues selon ledit procede |
| SK283420B6 (sk) * | 1992-05-08 | 2003-07-01 | Pharmacia & Upjohn Company | Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny |
| MY115155A (en) | 1993-09-09 | 2003-04-30 | Upjohn Co | Substituted oxazine and thiazine oxazolidinone antimicrobials. |
| DE69522234T2 (de) | 1994-10-26 | 2002-05-16 | Pharmacia & Upjohn Co., Kalamazoo | Phenyloxazolidinone mit antimikrobieller wirkung |
| US6124334A (en) | 1995-02-03 | 2000-09-26 | Pharmacia & Upjohn Company | Hetero-aromatic ring substituted phenyloxazolidinone antimicrobials |
| GB9601666D0 (en) | 1996-01-27 | 1996-03-27 | Zeneca Ltd | Chemical compounds |
| US6087496A (en) * | 1998-05-22 | 2000-07-11 | G. D. Searle & Co. | Substituted pyrazoles suitable as p38 kinase inhibitors |
| JPH11322729A (ja) * | 1998-03-09 | 1999-11-24 | Hokuriku Seiyaku Co Ltd | ジチオカルバミド酸誘導体 |
| CN1367780A (zh) | 1999-07-28 | 2002-09-04 | 法玛西雅厄普约翰美国公司 | 噁唑烷酮类化合物、其制备方法及其应用 |
| GB0118407D0 (en) | 2001-07-27 | 2001-09-19 | Cipla Ltd | Oxazolidinone derivatives as antibacterial agents |
-
2001
- 2001-11-26 YU YU52403A patent/YU52403A/sh unknown
- 2001-12-21 US US10/032,392 patent/US7030148B2/en not_active Expired - Fee Related
- 2001-12-26 CZ CZ20031799A patent/CZ20031799A3/cs unknown
- 2001-12-26 RU RU2003123104/04A patent/RU2322444C2/ru not_active IP Right Cessation
- 2001-12-26 PL PL01363616A patent/PL363616A1/xx not_active Application Discontinuation
- 2001-12-26 EE EEP200300254A patent/EE200300254A/xx unknown
- 2001-12-26 NZ NZ526716A patent/NZ526716A/en unknown
- 2001-12-26 HU HU0302580A patent/HUP0302580A2/hu unknown
- 2001-12-26 MX MXPA03005822A patent/MXPA03005822A/es not_active Application Discontinuation
- 2001-12-26 WO PCT/IN2001/000227 patent/WO2002051819A2/en not_active Ceased
- 2001-12-26 JP JP2002552914A patent/JP2004525876A/ja not_active Withdrawn
- 2001-12-26 HR HR20030522A patent/HRP20030522A2/hr not_active Application Discontinuation
- 2001-12-26 CA CA002433138A patent/CA2433138A1/en not_active Abandoned
- 2001-12-26 EP EP01995805A patent/EP1345913A2/en not_active Withdrawn
- 2001-12-26 IL IL15666201A patent/IL156662A0/xx unknown
- 2001-12-26 BR BR0116571-2A patent/BR0116571A/pt not_active IP Right Cessation
- 2001-12-26 KR KR10-2003-7008637A patent/KR20030063472A/ko not_active Ceased
- 2001-12-26 CN CNA018224210A patent/CN1656083A/zh active Pending
- 2001-12-26 SK SK820-2003A patent/SK8202003A3/sk not_active Application Discontinuation
-
2003
- 2003-06-25 NO NO20032926A patent/NO20032926L/no unknown
- 2003-07-22 BG BG108022A patent/BG108022A/bg unknown
- 2003-08-01 US US10/632,950 patent/US7183301B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2003123104A (ru) | Новые гетероциклические соединения, имеющие антибактериальную активность:способ их получения и фармацевтические композиции, содеержащие их | |
| JP3698724B2 (ja) | 置換−ヒドロキシアセチルピペラジンフェニルオキサゾリジノンのエステル | |
| RU2336275C2 (ru) | Пиримидопроизводные, характеризующиеся антипролиферативной активностью, и фармацевтическая композиция | |
| AU730856C (en) | Mesylate trihydrate salt of 5-(2-(4-(1,2-benzisothiazol- 3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2(1H)- indol-2-one(=ziprasidone),it's preparation and it's use as dopamine D2 antagonist | |
| CA2011346A1 (en) | 2-(1-piperazinyl)-4-phenylcycloalkanopyridine derivatives, processes for the production thereof, and pharmaceutical composition containing the same | |
| CA2431952A1 (en) | Muscarinic antagonists | |
| DK2266958T1 (da) | Antiviralt middel | |
| NZ335363A (en) | Naphthyridine derivatives | |
| HUT72296A (en) | Oxazolidinones containing a substituted diazine moiety and pharmaceutical compositions containing them having antimicrobial effect | |
| TR200100300T2 (tr) | Sitokinlerin üretiminde engelleyici olarak kullanışlı amid türevleri | |
| JP2003522763A (ja) | ピペラジンアミド置換基を持つオキサゾリジノンチオアミド | |
| RU2011136537A (ru) | Кристаллическая форма (r)-3-(4-(2-метилтетразол-5-ил)пиридин-5-ил)-3-фторфенил)-5-гидроксиметил оксазолидин-2-он диводород фосфата | |
| JP2022548247A5 (enExample) | ||
| CA2530140A1 (en) | Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof | |
| RU2007147346A (ru) | Новые производные 2-азетидинона в качестве ингибиторов всасывания холестерина для лечения гиперлипидемических состояний | |
| RU2007147344A (ru) | Новые производные 2-азетидинона для лечения гиперлипидемических заболеваний | |
| JP2004525183A5 (enExample) | ||
| RU2004130487A (ru) | Производные азетидина в качестве антагонистов ccr-3 рецептора | |
| JP2026503618A5 (enExample) | ||
| EP1519924A1 (en) | Difluorothioacetamides of oxazolidinones as antibacterial agents | |
| JP2008530045A5 (enExample) | ||
| JP2024540477A5 (enExample) | ||
| CA2490152A1 (en) | Oxazole derivatives and their use as insulin sensitizers | |
| ZA200304945B (en) | Heterocyclic compounds having antibacterial activity, process for their preparation and pharmaceutical compositions containing them. | |
| KR940002244A (ko) | 카르바페넴 화합물 |